PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2Viviana Simon, Florian Krammer, Loren G. Miller et al.|mSphere|2022Cited by 36
Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-AnalysisOlivia Kronick, Cassie S. Mitchell, Armon Varmeziar et al.|Cancers|2023Cited by 20
Gilteritinib Results in Higher Remission and Transplant Rates Than Midostaurin but Does Not Increase the Post-Induction Mutational MRD Negative Rate: Results of the Phase 2 Randomized Precog 0905 Study in Newly Diagnosed <i>FLT3</i> Mutated AMLSelina M. Luger, Mark R. Litzow, Ellin Berman et al.|Blood|2024Cited by 7